SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-127322
Filing Date
2023-04-28
Accepted
2023-04-28 16:42:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d415306ddefa14a.htm DEFA14A 8142
2 GRAPHIC g415306g30v42.jpg GRAPHIC 222817
3 GRAPHIC g415306g72o72.jpg GRAPHIC 168589
  Complete submission text file 0001193125-23-127322.txt   548345
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38959 | Film No.: 23867443
SIC: 2834 Pharmaceutical Preparations